News Items

We are excited about our new partnership with The Galien Foundation which oversees US operations for The Prix Galien Award, a prize that recognizes outstanding achievements in improving global human health through the development of innovative therapies.

Nine-TZ Healthcare Ventures LLC
640 East Broad Street
Westfield, NJ 07090

Tel +1 973 928 7753.

Michael Milken, founder of FasterCures, philanthropist and financier is our latest contributor and in this article analyzes US healthcare reform.

Drs Kevin Bilyard (Principal) and Gilles Devillers (Associate) presented at the recent EuroBio meeting held in Lille in September 2009.

We have formed a business relationship with Canaccord Adams, a leading independent full service investment bank.

Nine-TZ has expanded and we now offer more resources and greater depth to our services. Our new colleagues include a healthcare investment banker, a pharma forecasting professional, and a licensing and business executive, based in France.

The FT reports that the European Commission and the pharmaceutical industry this week unveiled a €2bn (£1.6bn) partnership to arrest the EU's declining international role in medical research.

We are delighted to note the publication of an article in Journal of Translational Medicine that describes a new and exciting technology with which Nine-TZ Healthcare Ventures is associated.

Nine-TZ US has moved to new offices in Metropolitan New Jersey. We are now located in the Gateway Center at Newark's Penn Station in downtown Newark, NJ.

A DESIGN company has seen its work go up in lights in New York – without the team having to leave its Holmfirth offices.

Nine-TZ Healthcare Ventures (Nine-TZ) is pleased to have been an international sponsor and marketing partner of the second Annual EQUITIES Magazine Transatlantic Conference.